Literature DB >> 22329969

Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs.

Luke E Grzeskowiak1, Andrew L Gilbert, Janna L Morrison.   

Abstract

In the absence of randomised controlled trials, knowledge of outcomes associated with medication use during pregnancy is dependent on observational studies. Numerous observational study designs exist, with the decision on which is most appropriate depending on a number of factors, including the exposure and outcome under investigation and knowledge of key methodological issues. This review provides an overview of the key methodological issues involved in undertaking observational studies to investigate medication use during pregnancy, including selection bias, exposure and outcome classification, information bias, confounding and statistical analysis. This review also discusses observational study types used to investigate outcomes associated with medication use during pregnancy and summarises their relative strengths and weaknesses. Knowledge of the strengths, weaknesses and methodological issues associated with observational studies can assist clinicians in making assessments about the validity and applicability of results presented in order to provide the best recommendations to patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22329969     DOI: 10.1016/j.reprotox.2012.01.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  10 in total

1.  Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Ther Adv Drug Saf       Date:  2013-02

2.  Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER).

Authors:  Emma Kalk; Alexa Heekes; Amy L Slogrove; Florence Phelanyane; Mary-Ann Davies; Landon Myer; Jonathan Euvrard; Max Kroon; Greg Petro; Karen Fieggen; Chantal Stewart; Natasha Rhoda; Stefan Gebhardt; Ayesha Osman; Kim Anderson; Andrew Boulle; Ushma Mehta
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

3.  Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment.

Authors:  Jani van der Hoven; Elizabeth Allen; Annibale Cois; Renee de Waal; Gary Maartens; Landon Myer; Thokozile Malaba; Hlengiwe Madlala; Dorothy Nyemba; Florence Phelanyane; Andrew Boulle; Ushma Mehta; Emma Kalk
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-03       Impact factor: 3.105

Review 4.  Using multiple types of studies in systematic reviews of health care interventions--a systematic review.

Authors:  Frank Peinemann; Doreen Allen Tushabe; Jos Kleijnen
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

5.  Drug use during early pregnancy: cross-sectional analysis from the Childbirth and Health Study in Primary Care in Iceland.

Authors:  Thury O Axelsdottir; Emil L Sigurdsson; Anna M Gudmundsdottir; Hildur Kristjansdottir; Johann A Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2014-10-09       Impact factor: 2.581

6.  Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study.

Authors:  Elizabeth N Allen; Melba Gomes; Lucy Yevoo; Omar Egesah; Christine Clerk; Josaphat Byamugisha; Anthony Mbonye; Edwin Were; Ushma Mehta; Lynn M Atuyambe
Journal:  BMC Health Serv Res       Date:  2014-10-31       Impact factor: 2.655

7.  Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

Authors:  Charlotte Gils; Anton Pottegård; Zandra Nymand Ennis; Per Damkier
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-17       Impact factor: 3.007

8.  Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database.

Authors:  Jingyuan Zhang; Carolina Oi Lam Ung; Anita Katharina Wagner; Xiaodong Guan; Luwen Shi
Journal:  Clin Epidemiol       Date:  2019-12-10       Impact factor: 4.790

9.  An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.

Authors:  Sally Stephens; Simon Hugh Lynton Thomas; Anna Jamry-Dziurla; Lolkje de Jong-van den Berg; Priscilla Zetstra-van der Woude; Maja Laursen; Valerie Hliva; Shahrul Mt-Isa; Alison Bourke; Nancy A Dreyer; Stella Cf Blackburn; Jonathan Luke Richardson
Journal:  JMIR Public Health Surveill       Date:  2016-03-18

Review 10.  Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy.

Authors:  Susan E Andrade; Anick Bérard; Hedvig M E Nordeng; Mollie E Wood; Marleen M H J van Gelder; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.